Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection

BACKGROUND: An effective therapeutic vaccine that could augment immune control of HIV-1 replication may abrogate or delay the need for antiretroviral therapy. AIDS Clinical Trials Group (ACTG) A5187 was a phase I/II, randomized, placebo-controlled, double-blinded trial to evaluate the safety and imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Eric S., Graham, Barney S., Chan, Ellen S., Bosch, Ronald J., Stocker, Vicki, Maenza, Janine, Markowitz, Martin, Little, Susan, Sax, Paul E., Collier, Ann C., Nabel, Gary, Saindon, Suzanne, Flynn, Theresa, Kuritzkes, Daniel, Barouch, Dan H.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866663/
https://www.ncbi.nlm.nih.gov/pubmed/20479938
http://dx.doi.org/10.1371/journal.pone.0010555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866663/
https://www.ncbi.nlm.nih.gov/pubmed/20479938
http://dx.doi.org/10.1371/journal.pone.0010555

Ejemplares similares